ArticleAnnals of internal medicine2020

Update Alert 4: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.

Katherine Mackey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.